FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/12/039007 [Registered on: 29/12/2021] Trial Registered Prospectively
Last Modified On: 27/12/2021
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Study of skin and biopsy features in children with Langerhans cell histiocytosis 
Scientific Title of Study   A cross-sectional descriptive study to characterize the cutaneous and histological features in children with Langerhans cell histiocytosis 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Avik Mondal 
Designation  Junior Resident 
Affiliation  ALL INSTITUTE OF MEDICAL SCIENCES 
Address  Skin OPD, RN 313, 3rd floor, Rajkumari Amrit Kaur OPD

New Delhi
DELHI
110029
India 
Phone  07908072776  
Fax    
Email  avik.mondal11@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Neetu Bhari 
Designation  Associate Professor 
Affiliation  ALL INSTITUTE OF MEDICAL SCIENCES 
Address  Teaching block, RN 4078A, 4th floor, AIIMS

New Delhi
DELHI
110029
India 
Phone  07908072776  
Fax    
Email  drntbhari@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Avik Mondal 
Designation  Junior Resident 
Affiliation  ALL INSTITUTE OF MEDICAL SCIENCES 
Address  Skin OPD, RN 313, 3rd floor, Rajkumari Amrit Kaur OPD

New Delhi
DELHI
110029
India 
Phone  07908072776  
Fax    
Email  avik.mondal11@gmail.com  
 
Source of Monetary or Material Support  
None 
 
Primary Sponsor  
Name  ALL INDIA INSTITUTE OF MEDICAL SCIENCES 
Address  ANSARI NAGAR, NEW DELHI 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Avik Mondal  All India Institute of Medical Science  Skin opd, RN 313, Rajkumari Amrit Kaur OPD, 3rd floor, AIIMS
New Delhi
DELHI 
7908072776

avik.mondal11@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L80-L99||Other disorders of the skin and subcutaneous tissue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  0.00 Day(s)
Age To  18.00 Year(s)
Gender  Both 
Details  Children with clinical and histological diagnosis of Langerhans cell histiocytosis 
 
ExclusionCriteria 
Details  1. Children with a doubtful diagnosis of Langerhans cell histiocytosis
2. Parents not willing to participate in this study
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
Description of clinical and histological features in children with Langerhans cell histiocytosis  Baseline 
 
Secondary Outcome  
Outcome  TimePoints 
Correlation of these clinical and histological features with frequency and severity of systemic involvement in children with Langerhans cell histiocytosis  Baseline 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/01/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Langerhans cell histiocytosis is a clonal proliferative disorder of histiocytes characterized by accumulation of CD1a + Langerhans cells in various organs. There is a scarcity of information regarding various cutaneous and histological presentations of this disease. Some studies have indicated a prognostic role of few cutaneous and histological findings of Langerhans cell histiocytosis. Thus, this study will aim to describe the clinical and histological findings of this condition and their correlation with frequency and severity of systemic involvement. 
Close